MenopauseNCT07695051
Effect of Cold Shower Therapy on Hot Flashes And Night Sweats in Menopausal Women
A study testing Cold Shower Therapy in people with Menopause and Hot Flashes, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. Read more about this study
- Who is it for?
- Ages 40 to 65 years, women only
- Conditions the study is for
- Menopause, Hot Flashes, Night Sweats
- What is being tested?
- Cold Shower Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Jan 2026to 7 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Able to read, write, and understand the study procedures.
- Women aged 40-65 years.
- Postmenopausal women experiencing hot flashes and/or night sweats.
- Not receiving hormone replacement therapy (HRT) for vasomotor symptoms.
- No known medical contraindication to cold shower therapy.
- Willing to participate and able to provide written informed consent.
Who cannot join
- History of serious chronic diseases that may affect hemodynamic stability (e.g., cardiovascular disease, uncontrolled hypertension, renal failure, or liver failure).
- Current use of antidepressant or antipsychotic medications, or diagnosis of a severe psychiatric disorder.
- Regular use of cold shower or cold-water therapy before enrollment.
- Incomplete completion of study questionnaires or data collection forms
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Buyukada Central Family Health Center, Unit 001
Istanbul, Istanbul
About this study
Official title: Effect of Cold Shower Therapy on Hot Flashes and Night Sweats in Menopausal Women
This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. The primary outcome is the change in the frequency and severity of hot flashes and night sweats after the 6-week intervention.
Read the detailed description
Menopausal hot flashes and night sweats are common vasomotor symptoms that negatively affect quality of life. This randomized controlled trial investigates the effectiveness of a 6-week cold shower therapy as a non-pharmacological intervention for reducing these symptoms. Eligible menopausal women will be randomly assigned to an intervention group or a control group. The intervention group will receive cold shower therapy for six weeks, while the control group will receive routine care. Outcomes will be assessed before and after the intervention using validated measurement tools. The study aims to determine whether cold shower therapy is an effective, safe, and low-cost method for managing menopausal vasomotor symptoms.
- Conditions
- Menopause, Hot Flashes, Night Sweats
- Being tested
- Cold Shower Therapy
- Keywords
- menopause, hot flashes, night sweats, cold shower therapy
- Medical subject headings
- Hot Flashes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cold Shower TherapyBehavioural
Participants in the intervention group received daily cold shower therapy for 6 weeks. Water temperature was maintained at 15-20°C using a thermometer provided to participants. The control group received routine care without cold shower therapy. Outcomes were assessed at baseline and after 6 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Cold Shower Therapy | Experimental | Participants received cold shower therapy for 6 weeks. Receives: Behavioral: Cold Shower Therapy |
| Control | No intervention | Participants received routine care and no cold shower therapy during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Hot Flash and Night Sweat Frequency and Severity
Change in the frequency and severity of hot flashes and night sweats measured at baseline, week 3 and week 6.
Measured: Baseline, Week 3, Week 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2026
- Study start30 Jan 2026
- Primary completion7 Jul 2026
- Study completion7 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MenopauseStudies of the same condition, open and under way.
- More trials run by Istanbul University - CerrahpasaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants were randomly assigned to either the cold shower therapy group or the control group and followed in parallel for 6 weeks.
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Beyza AYDIN ATALAY, Istanbul University - Cerrahpasa
- Investigators
- Nuran Gencturk, PhD, Principal investigator, Istanbul University - Cerrahpasa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07695051
- Sponsor's protocol ID
- BAA-2026-001
- Status last verified
- Jul 2026
- First submitted
- 6 Jul 2026
- Last updated
- 10 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Cold Shower Therapy on Hot Flashes and Night Sweats in Menopausal Women
- ClinicalTrials.gov ID
- NCT07695051
- Acronym / sponsor ID
- BAA-2026-001
- Conditions
- Menopause, Hot Flashes, Night Sweats
- Keywords
- menopause, hot flashes, night sweats, cold shower therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 30 Jan 2026 (actual)
- Primary completion
- 7 Jul 2026 (actual)
- Study completion
- 7 Jul 2026 (actual)
- First posted
- 10 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. The primary outcome is the change in the frequency and severity of hot flashes and night sweats after the 6-week intervention.
Detailed description
Menopausal hot flashes and night sweats are common vasomotor symptoms that negatively affect quality of life. This randomized controlled trial investigates the effectiveness of a 6-week cold shower therapy as a non-pharmacological intervention for reducing these symptoms. Eligible menopausal women will be randomly assigned to an intervention group or a control group. The intervention group will receive cold shower therapy for six weeks, while the control group will receive routine care. Outcomes will be assessed before and after the intervention using validated measurement tools. The study aims to determine whether cold shower therapy is an effective, safe, and low-cost method for managing menopausal vasomotor symptoms.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants were randomly assigned to either the cold shower therapy group or the control group and followed in parallel for 6 weeks.
| Arm | Type | Receives |
|---|---|---|
| Cold Shower Therapy | Experimental | Behavioral: Cold Shower TherapyParticipants received cold shower therapy for 6 weeks. |
| Control | No intervention | –Participants received routine care and no cold shower therapy during the study period. |
Who may qualify
- Ages
- 40 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Able to read, write, and understand the study procedures.
- Women aged 40-65 years.
- Postmenopausal women experiencing hot flashes and/or night sweats.
- Not receiving hormone replacement therapy (HRT) for vasomotor symptoms.
- No known medical contraindication to cold shower therapy.
Key exclusion criteria (4 listed)
- History of serious chronic diseases that may affect hemodynamic stability (e.g., cardiovascular disease, uncontrolled hypertension, renal failure, or liver failure).
- Current use of antidepressant or antipsychotic medications, or diagnosis of a severe psychiatric disorder.
- Regular use of cold shower or cold-water therapy before enrollment.
- Incomplete completion of study questionnaires or data collection forms
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cold Shower TherapyParticipants in the intervention group received daily cold shower therapy for 6 weeks. Water temperature was maintained at 15-20°C using a thermometer provided to participants. The control group received routine care without cold shower therapy. Outcomes were assessed at baseline and after 6 weeks. | Behavioural | Cold Shower Therapy |
Primary outcome
Change in Hot Flash and Night Sweat Frequency and Severity
Time frame: Baseline, Week 3, Week 6
Change in the frequency and severity of hot flashes and night sweats measured at baseline, week 3 and week 6.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Menopause
Recruiting
Hop Extract Versus Soy Isoflavone Extract for Menopausal Symptoms (HOPES)
Menopause, Perimenopause
Not yet recruiting
The Role of Diet Quality in Sleep Among Women in Postmenopause
Post Menopausal Women
Active, not recruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Infertility (IVF Patients)
Not yet recruiting
Effect of Hormone Replacement Therapy on Physiotherapy Outcomes in Postmenopausal Women With Frozen Shoulder
Frozen Shoulder, Adhesive Capsulitis
RecruitingObservational study
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nuran Gencturk, PhD principal investigator
Istanbul University - Cerrahpasa
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cold Shower Therapy in people with Menopause and Hot Flashes, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Hot Flash and Night Sweat Frequency and Severity (time frame: Baseline, Week 3, Week 6). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2026.